CompletedNCT01651364
Cabergoline Compared With Placebo for Cocaine Cravings
About this title
Read the official source — NCT01651364Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateJuly 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 11
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01651364
- Official title
Show the full official title
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Baylor College of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including Placebo and Cabergoline.
Who was this study for?
Listed age limits: 18 years to 55 years.
